Further analysis of these two databases revealed that the expression of SNF5 is higher in human NSCLC tissues than in normal tissues and NSCLC patients with high SNF5 expression had a shorter overall survival than those with low SNF5 expression. The gene discussed is SMARCB1; the disease is non-small cell lung carcinoma.